Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
PHILADELPHIA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Strados Labs, creator of the world’s first remote respiratory monitoring platform, announced today the addition of three new executives to its...
-
TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) (“Flow Capital”) today announced its financial and operating results for the three-month and twelve-month periods ended...
-
SAN MATEO, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Alluxio, developer of the world's first software system that unifies data at memory speed, will host a free webinar on Feb 13, 2019 at 10am PST...
-
Conference Call Scheduled for Tuesday, February 12th at 11:30 AM EST NORTHVALE, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
-
CALGARY, Alberta, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Cardinal Energy Ltd. ("Cardinal" or the "Company") (TSX: CJ) confirms that a dividend of $0.01 per common share will be paid on March 15, 2019 to...
-
MEMPHIS, Tenn., Feb. 11, 2019 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE:AZO), the nation’s leading auto parts retailer and a leading distributor of automotive replacement parts and accessories, will...
-
SAN JOSE, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Quantenna Communications, Inc. (NASDAQ:QTNA), a global leader and innovator of high performance Wi-Fi solutions, today announced that it will...
-
MALVERN, Pa., Feb. 11, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2018 earnings on Thursday, February 21 at 4:00 PM Eastern Time. The BioTelemetry...
-
LAKE FOREST, Ill., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release...
-
CAMBRIDGE, Mass., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to...